Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Payables and Accruals [Abstract]
Accrued payments due to AstraZeneca	$ 12,077	$ 3,680
Accrued gross to net revenue liabilities	10,112	3,258
Accrued sales and marketing expenses	3,696	3,223
Other	8,757	4,880
Total accrued expenses and other current liabilities	$ 34,642	$ 15,041